γδβ-Thalassemia due to a de novo mutation deleting the 5' β-globin gene activation-region hypersensitive sites

M. C. Driscoll, C. S. Dobkin, B. P. Alter

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

γδβ-Thalassemia is a rare disorder of hemoglobin biosynthesis, characterized molecularly by partial or complete deletions of the β-globin gene complex of 100 kilobases (kb) or greater. Common to all mutants described has been the deletion of the most-5' sequences of the β-globin complex. We have used the techniques of pulsed field gel electrophoresis and polymerase chain reaction to study a patient with a clinical γδβ-thalassemia phenotype. This subject developed a de novo deletion on a maternally inherited β-globin gene chromosome involving ~30 kb of sequences 5' to the ε gene; the deletion extends from -9.5 kb to -39 kb 5' of ε and includes three of the four DNase I hypersensitive sites (at -10.9 kb, -14.7 kb, and -18 kb 5' of ε). The remaining sequences of the β-globin complex, including the DNase I hypersensitive sites at -6.1 kb and all structural genes in cis to the deletion are physically intact, but presumably nonfunctional, as evidenced by the presence of a β(s)-globin gene that is not expressed as a sickle hemoglobin. Deletion of DNase I hypersensitive sites on a previously functional β-globin gene complex confirms the significance of these sites in regulating globin gene expression.

Original languageEnglish (US)
Pages (from-to)7470-7474
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume86
Issue number19
StatePublished - 1989

Fingerprint

Thalassemia
Globins
Transcriptional Activation
Mutation
Deoxyribonuclease I
Genes
Sickle Hemoglobin
Pulsed Field Gel Electrophoresis
Gene Deletion
Hemoglobins
Chromosomes
Phenotype
Gene Expression
Polymerase Chain Reaction

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

γδβ-Thalassemia due to a de novo mutation deleting the 5' β-globin gene activation-region hypersensitive sites. / Driscoll, M. C.; Dobkin, C. S.; Alter, B. P.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 86, No. 19, 1989, p. 7470-7474.

Research output: Contribution to journalArticle

@article{57675b01e2b94cbc95bba26be9477a93,
title = "γδβ-Thalassemia due to a de novo mutation deleting the 5' β-globin gene activation-region hypersensitive sites",
abstract = "γδβ-Thalassemia is a rare disorder of hemoglobin biosynthesis, characterized molecularly by partial or complete deletions of the β-globin gene complex of 100 kilobases (kb) or greater. Common to all mutants described has been the deletion of the most-5' sequences of the β-globin complex. We have used the techniques of pulsed field gel electrophoresis and polymerase chain reaction to study a patient with a clinical γδβ-thalassemia phenotype. This subject developed a de novo deletion on a maternally inherited β-globin gene chromosome involving ~30 kb of sequences 5' to the ε gene; the deletion extends from -9.5 kb to -39 kb 5' of ε and includes three of the four DNase I hypersensitive sites (at -10.9 kb, -14.7 kb, and -18 kb 5' of ε). The remaining sequences of the β-globin complex, including the DNase I hypersensitive sites at -6.1 kb and all structural genes in cis to the deletion are physically intact, but presumably nonfunctional, as evidenced by the presence of a β(s)-globin gene that is not expressed as a sickle hemoglobin. Deletion of DNase I hypersensitive sites on a previously functional β-globin gene complex confirms the significance of these sites in regulating globin gene expression.",
author = "Driscoll, {M. C.} and Dobkin, {C. S.} and Alter, {B. P.}",
year = "1989",
language = "English (US)",
volume = "86",
pages = "7470--7474",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "19",

}

TY - JOUR

T1 - γδβ-Thalassemia due to a de novo mutation deleting the 5' β-globin gene activation-region hypersensitive sites

AU - Driscoll, M. C.

AU - Dobkin, C. S.

AU - Alter, B. P.

PY - 1989

Y1 - 1989

N2 - γδβ-Thalassemia is a rare disorder of hemoglobin biosynthesis, characterized molecularly by partial or complete deletions of the β-globin gene complex of 100 kilobases (kb) or greater. Common to all mutants described has been the deletion of the most-5' sequences of the β-globin complex. We have used the techniques of pulsed field gel electrophoresis and polymerase chain reaction to study a patient with a clinical γδβ-thalassemia phenotype. This subject developed a de novo deletion on a maternally inherited β-globin gene chromosome involving ~30 kb of sequences 5' to the ε gene; the deletion extends from -9.5 kb to -39 kb 5' of ε and includes three of the four DNase I hypersensitive sites (at -10.9 kb, -14.7 kb, and -18 kb 5' of ε). The remaining sequences of the β-globin complex, including the DNase I hypersensitive sites at -6.1 kb and all structural genes in cis to the deletion are physically intact, but presumably nonfunctional, as evidenced by the presence of a β(s)-globin gene that is not expressed as a sickle hemoglobin. Deletion of DNase I hypersensitive sites on a previously functional β-globin gene complex confirms the significance of these sites in regulating globin gene expression.

AB - γδβ-Thalassemia is a rare disorder of hemoglobin biosynthesis, characterized molecularly by partial or complete deletions of the β-globin gene complex of 100 kilobases (kb) or greater. Common to all mutants described has been the deletion of the most-5' sequences of the β-globin complex. We have used the techniques of pulsed field gel electrophoresis and polymerase chain reaction to study a patient with a clinical γδβ-thalassemia phenotype. This subject developed a de novo deletion on a maternally inherited β-globin gene chromosome involving ~30 kb of sequences 5' to the ε gene; the deletion extends from -9.5 kb to -39 kb 5' of ε and includes three of the four DNase I hypersensitive sites (at -10.9 kb, -14.7 kb, and -18 kb 5' of ε). The remaining sequences of the β-globin complex, including the DNase I hypersensitive sites at -6.1 kb and all structural genes in cis to the deletion are physically intact, but presumably nonfunctional, as evidenced by the presence of a β(s)-globin gene that is not expressed as a sickle hemoglobin. Deletion of DNase I hypersensitive sites on a previously functional β-globin gene complex confirms the significance of these sites in regulating globin gene expression.

UR - http://www.scopus.com/inward/record.url?scp=0012953756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0012953756&partnerID=8YFLogxK

M3 - Article

C2 - 2798417

AN - SCOPUS:0012953756

VL - 86

SP - 7470

EP - 7474

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 19

ER -